Description:
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
XPA, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Nucleotide and Nucleic Acid Metabolism |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
Black/African American
|
Family Member
|
2
|
Relation to Proband
|
third cousin
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
3 |
|
Gene |
XPA |
Chromosomal Location |
9q22.3-q31 |
Allelic Variant 1 |
no splice site; XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A |
Identified Mutation |
389G>A |
|
Gene |
XPA |
Chromosomal Location |
9q22.3-q31 |
Allelic Variant 2 |
no splice site; XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A |
Identified Mutation |
389G>A |
Remarks |
XP5JO; African; blindness due to corneal opacity; skin shows areas of hypo- and hyperpigmentation but no malignancies; offspring of consanguineous parents; donor subject is homozygous G-to-A substitution at nucleotide 389 (389G>A) in exon 3 of the XPA gene which results in no splice site. |
States JC, McDuffie ER, Myrand SP, McDowell M, Cleaver JE, Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. Hum Mutat12:103-13 1998 |
PubMed ID: 9671271 |
|
Abrahams PJ, van der Kleij AA, Schouten R, van der Eb AJ, Absence of induction of enhanced reactivation of herpes simplex virus in cells from xeroderma pigmentosum patients without skin cancer. Cancer Res48:6054-7 1988 |
PubMed ID: 2844398 |
Passage Frozen |
3 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|